Trade Abbvie - ABBV CFD

Add to favourite

201.80

0.54%

0.39

Low: 200.3

High: 203.66

Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

Summary
Historical Data

Trading сonditions

Spread

0.39

Long position overnight fee

-0.023512%

Short position overnight fee

0.00129%

Overnight fee time

22:00 (UTC)

Min traded quantity

0.1

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	200.72
Open	200.3
1-Year Change	14.11%
Day's Range	200.3 - 203.66

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 20, 2025	200.72	2.93	1.48%	197.79	201.25	196.64
Feb 19, 2025	197.28	0.60	0.31%	196.68	197.92	195.95
Feb 18, 2025	196.13	4.73	2.47%	191.40	196.93	191.40
Feb 14, 2025	192.74	-0.35	-0.18%	193.09	194.98	192.58
Feb 13, 2025	193.34	0.67	0.35%	192.67	194.04	190.80
Feb 12, 2025	192.87	2.61	1.37%	190.26	194.19	189.78
Feb 11, 2025	191.69	2.20	1.16%	189.49	191.86	187.97
Feb 10, 2025	190.24	-0.58	-0.30%	190.82	191.17	188.97
Feb 7, 2025	190.53	-1.48	-0.77%	192.01	193.59	190.36
Feb 6, 2025	192.77	1.63	0.85%	191.14	194.35	189.88
Feb 5, 2025	191.64	1.47	0.77%	190.17	193.27	189.58
Feb 4, 2025	189.79	3.94	2.12%	185.85	191.03	185.85
Feb 3, 2025	190.03	7.64	4.19%	182.39	191.56	181.95
Jan 31, 2025	183.19	-2.72	-1.46%	185.91	191.34	183.19
Jan 30, 2025	175.49	-0.07	-0.04%	175.56	176.03	173.69
Jan 29, 2025	175.07	0.78	0.45%	174.29	176.81	174.20
Jan 28, 2025	174.68	-1.66	-0.94%	176.34	176.95	173.66
Jan 27, 2025	176.77	3.98	2.30%	172.79	177.35	172.54
Jan 24, 2025	169.83	0.66	0.39%	169.17	171.03	168.95
Jan 23, 2025	170.58	0.38	0.22%	170.20	170.60	168.41

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

AbbVie Company profile

AbbVie Inc. is a research-based pharmaceutical company, specialising in the discovery and development of biopharmaceuticals and small molecule drugs. With a team of around 29,000 scientists, researchers, manufacturing specialists and communications professionals across the globe, the company introduces new approaches to treating chronic conditions and life-threatening health issues. In 2019, AbbVie was ranked 96th on the Fortune 500 list of America’s biggest companies. More than 30 million patients in over 170 countries are treated by AbbVie’s medicines annually.

Headquartered in North Chicago, Illinois, AbbVie has 22 primary research and manufacturing facilities around the world. The company’s research centres are in the US, Germany and Japan; and its manufacturing sites are located in the USA, Puerto Rico, Ireland, Germany, Italy and Singapore.

The company produces medicines aimed at treating autoimmune diseases, cancers, viruses (including hepatitis C and HIV), neurological and metabolic disorders. According to the Wall Street Journal, in 2016, a specialty drug ibrutinib, retailed by the company, cost from $116,600 to $155,400 a year wholesale in the US. AbbVie estimates global sales of the drug at $5 billion in 2020.

The history of AbbVie started in 2013 when Abbott Laboratories split into two publicly traded companies. One, using the old company name, was to specialise in medical equipment and devices and nutritional products; the other, AbbVie, was to be a research-driven pharmaceutical manufacturer. From the start, AbbVie was interested in acquisitions: in 2014, it acquired ImmuVen for an undisclosed amount, and in 2015, AbbVie acquired oncology firm Pharmacyclics and its treatment for blood cancers.

Presently, the AbbVie share price is listed on the New York Stock Exchange (NYSE). It is also a constituent of both the S&P 100 and 500 indices. In 2018, AbbVie reported its annual revenues of over $32.75 billion. During the same year, the ABBV stock price hit an all-time high of $123. As of July 2019, the company’s market capitalisation was set at around $106.13 billion.

Get the latest news on the Abbvie share price and stay on top of the ABBV share price chart with Capital.com.

Industry:

Pharmaceuticals (NEC)

1 N Waukegan Rd
NORTH CHICAGO
ILLINOIS 60064
US

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025